Tri Locum Partners’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.4M Sell
255,332
-9,683
-4% -$2.17M 8.2% 4
2025
Q4
$56.5M Buy
265,015
+90,186
+52% +$18.6M 7.34% 5
2025
Q3
$34.8M Buy
174,829
+27,187
+18% +$5.07M 7.99% 5
2025
Q2
$25.5M Buy
147,642
+115,317
+357% +$18.8M 7.73% 5
2025
Q1
$5.04M Buy
+32,325
New +$4.62M 2.59% 15
2024
Q3
Sell
-227,762
Closed -$31.1M 23
2024
Q2
$31.1M Buy
227,762
+115,092
+102% +$15.7M 7.85% 3
2024
Q1
$17M Buy
112,670
+13,120
+13% +$1.87M 5.91% 5
2023
Q4
$12.5M Buy
+99,550
New +$9.93M 6.15% 6
2023
Q1
Sell
-99,215
Closed -$12.1M 53
2022
Q4
$12.1M Buy
+99,215
New +$11.5M 5.36% 7

Other funds holding ASND